Today: 9 June 2026
Browse Category

NYSE:TOST 20 October 2025 - 19 December 2025

Toast (TOST) Stock on December 4, 2025: Analyst Upgrades, AI Strategy and Earnings Shape a High‑Growth, High‑Valuation Story

Toast (TOST) Stock on December 4, 2025: Analyst Upgrades, AI Strategy and Earnings Shape a High‑Growth, High‑Valuation Story

Toast, Inc. traded at $35.17 per share with a market cap of $20.68 billion in early December 2025. JPMorgan upgraded the stock to Overweight with a $43 target on December 4, while UBS reiterated a Buy rating and $50 target the same day. BNP Paribas Exane raised its rating to Outperform with a $40 target on December 1. The stock’s valuation remains high, with a trailing P/E in the high-70s to low-80s.
4 December 2025
····
AI Stock Frenzy: Growth Stocks Go Parabolic as Tech Rally Surges

AI Stock Frenzy: Growth Stocks Go Parabolic as Tech Rally Surges

The Nasdaq hit about 22,680 and the S&P 500 hovered near 6,664 as investors poured into AI-driven growth stocks. Nvidia surged nearly 60% year-over-year, while AMD almost doubled in 2025 after major AI chip deals. CrowdStrike traded near record highs, up 56% annually. Analysts remain bullish, but some warn valuations are stretched.
20 October 2025
·········

Stock Market Today

  • SpaceX IPO 2026: Key Facts and Considerations
    June 8, 2026, 6:15 PM EDT. SpaceX, Elon Musk's private aerospace giant, is eyeing an initial public offering (IPO) in 2026. An IPO is when a company offers its shares to the public for the first time. Investors anticipating the SpaceX IPO should note the company's role in satellite technology and space exploration, sectors poised for growth. Market watchers will monitor valuation, timing, and regulatory factors as SpaceX transitions from private funding to public markets. Understanding these elements is crucial for stakeholders considering exposure to aerospace innovation and potential returns.

Latest articles

Volatility Gauge Jumps While Chip Stocks Swing

Volatility Gauge Jumps While Chip Stocks Swing

9 June 2026
The VIX plunged 12% to 18.92 as chip stocks rebounded sharply, with the Philadelphia Semiconductor Index jumping 5.6% and Intel soaring 11.2% after a major Google order, clawing back part of Friday’s $1.3 trillion rout; investors remain cautious ahead of key inflation data, interest rate decisions, and Middle East risks.
UBS Puts $850 Target on Cummins as AI Data Center Wave Fuels Shares

UBS Puts $850 Target on Cummins as AI Data Center Wave Fuels Shares

9 June 2026
UBS upgraded Cummins to Buy and hiked its price target to $850 from $565, citing surging data-center backup power demand and a stronger North American truck cycle; Cummins shares jumped 3.3% to $672.68 as UBS projected 2028 EPS of $41.25, topping consensus, and flagged double-digit Power business growth and raised long-term targets as key drivers.
UiPath Stock Slips Near $11 as Wall Street Questions the AI Automation Bounce

UiPath Stock Slips Near $11 as Wall Street Questions the AI Automation Bounce

8 June 2026
UiPath shares dipped 0.7% to $11.17 despite a strong quarter and raised outlook, as investors focused on slow annual recurring revenue growth and analyst caution, with Morgan Stanley cutting its price target and BofA maintaining Underperform, citing the need for clearer evidence that AI-driven automation can accelerate durable contract revenue.
IREN Shares Rally After Bitcoin Rebound and $4.4 Billion AI Data Center Move

IREN Shares Rally After Bitcoin Rebound and $4.4 Billion AI Data Center Move

8 June 2026
IREN surged 9% to $59.19 as investors returned to crypto and AI infrastructure stocks after last week’s selloff, driven by a $3.65 billion investment-grade GPU financing to support its Microsoft AI cloud contract and news of a planned 800MW data-center in Australia, but future gains hinge on execution, contract delivery, and bitcoin price stability.
SmartKem Shares Jump 100% on SRx Investment, SMTK in Focus

SmartKem Shares Jump 100% on SRx Investment, SMTK in Focus

8 June 2026
SmartKem shares soared as much as 150% to $1.135 before settling at $0.84 after SRx Health Solutions disclosed a 4.99% stake and purchase of convertible preferred securities, injecting new investor interest as SmartKem faces a Sept. 1 Nasdaq delisting risk for trading below $1 and warns of “substantial doubt” about its ability to continue as a going concern.
Go toTop